Current landscape of long COVID clinical trials
Manojit Bhattacharya(Fakir Mohan University), Chiranjib Chakraborty(Hallym University), Sanskriti Saxena(Indian Institute of Science Education and Research, Tirupati), Sang‐Soo Lee(Hallym University), Srijan Chatterjee(Hallym University), Shyam Sundar Nandi(Haffkine Institute)
Cited by 11
Related Papers
Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine
|Molecular Therapy — Nucleic Acids|2017|727
Development of epitope‐based peptide vaccine against novel coronavirus 2019 (SARS‐COV‐2): Immunoinformatics approach
|Journal of Medical Virology|2020|424
Therapeutic advances of miRNAs: A preclinical and clinical update
|Journal of Advanced Research|2020|404
Zebrafish: A complete animal model to enumerate the nanoparticle toxicity
|Journal of Nanobiotechnology|2016|344